113 related articles for article (PubMed ID: 27286973)
1. Decision-making around antithrombotics for stroke prevention in atrial fibrillation: the health professionals' views.
Wang Y; Bajorek B
Int J Clin Pharm; 2016 Aug; 38(4):985-95. PubMed ID: 27286973
[TBL] [Abstract][Full Text] [Related]
2. Patient values and preferences in decision making for antithrombotic therapy: a systematic review: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
MacLean S; Mulla S; Akl EA; Jankowski M; Vandvik PO; Ebrahim S; McLeod S; Bhatnagar N; Guyatt GH
Chest; 2012 Feb; 141(2 Suppl):e1S-e23S. PubMed ID: 22315262
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial to assess the impact of an antithrombotic decision aid in patients with nonvalvular atrial fibrillation: the DAAFI trial protocol [ISRCTN14429643].
McAlister FA; Man-Son-Hing M; Straus SE; Ghali WA; Gibson P; Anderson D; Cox J; Fradette M;
BMC Cardiovasc Disord; 2004 May; 4():5. PubMed ID: 15128463
[TBL] [Abstract][Full Text] [Related]
4. Exploring barriers to optimal anticoagulation for atrial fibrillation: interviews with clinicians.
Decker C; Garavalia L; Garavalia B; Simon T; Loeb M; Spertus JA; Daniel WC
J Multidiscip Healthc; 2012; 5():129-35. PubMed ID: 22936848
[TBL] [Abstract][Full Text] [Related]
5. Seeking help for atrial fibrillation: the role of the body in distributed decision making.
Hawking MKD; Swinglehurst D
Soc Sci Med; 2024 Jun; 350():116944. PubMed ID: 38728979
[TBL] [Abstract][Full Text] [Related]
6. Adoption of antithrombotic stewardship and utilization of clinical decision support systems-A questionnaire-based survey in Dutch hospitals.
Graafsma J; Klopotowska JE; Derijks HJ; van de Garde EMW; Hoge RHL; Kruip MJHA; Meijer K; Karapinar-Carkit F; van den Bemt PMLA
PLoS One; 2024; 19(6):e0306033. PubMed ID: 38905283
[TBL] [Abstract][Full Text] [Related]
7. Healthcare professionals' perspectives on oral health care in acute stroke patients: a qualitative study.
Konadu AB; Iwuozo EU; Sunkwa-Mills G; Ayoola YA; Manu EA; Hewlett SA; Dedey F; Abdulkadir MB; Ogedegbe O
BDJ Open; 2024 Jun; 10(1):52. PubMed ID: 38898008
[TBL] [Abstract][Full Text] [Related]
8. Clinical decisions for appropriate management of patients with atrial fibrillation.
Boriani G; Bonini N; Imberti JF; Vitolo M; Gerra L; Mantovani M; Serafini K; Birtolo C; Tartaglia E; Mei DA
Panminerva Med; 2024 Apr; ():. PubMed ID: 38656767
[TBL] [Abstract][Full Text] [Related]
9. Implementation issues and barriers for assessing oral health in dependent patients after stroke: A qualitative study.
BaHammam F; Durham J; Abdulmohsen B; Wassall R; McCracken GI
J Dent; 2024 Apr; 143():104896. PubMed ID: 38387596
[TBL] [Abstract][Full Text] [Related]
10. Management of ischaemic stroke survivors in primary care setting: the road to holistic care.
Ozdemir H; Sagris D; Abdul-Rahim AH; Lip GYH; Shantsila E
Intern Emerg Med; 2024 Apr; 19(3):609-618. PubMed ID: 37875703
[TBL] [Abstract][Full Text] [Related]
11. Does evidence really matter? Professionals' opinions on the practice of early mobilization after stroke.
Sjöholm A; Skarin M; Linden T; Bernhardt J
J Multidiscip Healthc; 2011; 4():367-76. PubMed ID: 22096341
[TBL] [Abstract][Full Text] [Related]
12. Intracerebral Hematoma Occurring During Warfarin Versus Non-Vitamin K Antagonist Oral Anticoagulant Therapy.
Takahashi H; Jimbo Y; Takano H; Abe H; Sato M; Fujii Y; Aizawa Y
Am J Cardiol; 2016 Jul; 118(2):222-5. PubMed ID: 27289294
[TBL] [Abstract][Full Text] [Related]
13. Antithrombotic therapy use in patients with atrial fibrillation before the era of non-vitamin K antagonist oral anticoagulants: the Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation (GLORIA-AF) Phase I cohort.
Huisman MV; Ma CS; Diener HC; Dubner SJ; Halperin JL; Rothman KJ; Teutsch C; Schoof N; Kleine E; Bartels DB; Lip GY;
Europace; 2016 Sep; 18(9):1308-18. PubMed ID: 27335063
[TBL] [Abstract][Full Text] [Related]
14. Bleeding in patients with atrial fibrillation treated with dabigatran, rivaroxaban or warfarin: A retrospective population-based cohort study.
Ellis MH; Neuman T; Bitterman H; Dotan SG; Hammerman A; Battat E; Eikelboom JW; Ginsberg JS; Hirsh J
Eur J Intern Med; 2016 Sep; 33():55-9. PubMed ID: 27296588
[TBL] [Abstract][Full Text] [Related]
15. Utilization of antithrombotic therapy for stroke prevention in atrial fibrillation: a cross-sectional baseline analysis in general practice.
Bajorek B; Magin PJ; Hilmer S; Krass I
J Clin Pharm Ther; 2016 Aug; 41(4):432-40. PubMed ID: 27338004
[TBL] [Abstract][Full Text] [Related]
16. Early introduction of direct oral anticoagulants in cardioembolic stroke patients with non-valvular atrial fibrillation.
Cappellari M; Carletti M; Danese A; Bovi P
J Thromb Thrombolysis; 2016 Oct; 42(3):393-8. PubMed ID: 27329483
[TBL] [Abstract][Full Text] [Related]
17. Visual Aid Tool to Improve Decision Making in Anticoagulation for Stroke Prevention.
Saposnik G; Joundi RA
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2380-5. PubMed ID: 27318647
[TBL] [Abstract][Full Text] [Related]
18. The anticoagulation choices of internal medicine residents for stroke prevention in non-valvular atrial fibrillation.
Moulson N; McIntyre WF; Oqab Z; Yazdan-Ashoori P; Quinn KL; van Oosten E; Hopman WM; Baranchuk A
Postgrad Med J; 2017 Jun; 93(1100):308-312. PubMed ID: 27307471
[TBL] [Abstract][Full Text] [Related]
19. NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tank.
Reiffel JA; Weitz JI; Reilly P; Kaminskas E; Sarich T; Sager P; Seltzer J;
Am Heart J; 2016 Jul; 177():74-86. PubMed ID: 27297852
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Crushed Tablet for Oral Administration and the Effect of Food on Apixaban Pharmacokinetics in Healthy Adults.
Song Y; Chang M; Suzuki A; Frost RJ; Kelly A; LaCreta F; Frost C
Clin Ther; 2016 Jul; 38(7):1674-1685.e1. PubMed ID: 27292282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
